FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Robert Camp

Research Profile

Procedures

Chemicals & Drugs

Disorders

Concepts & Ideas

Co-author Network

Publications

TOP 3
Saadia A Aziz; Robert L Camp; John W Colberg; Adebowale Adeniran; Joshua Sznol; Harriet M Kluger
Vascularity of primary and metastatic renal cell carcinoma specimens.
Lucia B Jilaveanu; Harriet M Kluger; Joshua Sznol; Saadia A Aziz; Dylan Duchen; Robert L Camp
CD70 expression patterns in renal cell carcinoma.
Anees B Chagpar; Robert L Camp; David L Rimm
Lymph node ratio should be considered for incorporation into staging for breast cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Robert Camp (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Saadia A Aziz; Robert L Camp; John W Colberg; Adebowale Adeniran; Joshua Sznol; Harriet M Kluger
Vascularity of primary and metastatic renal cell carcinoma specimens.
Journal of translational medicine 2013;11():15.
2012: Lucia B Jilaveanu; Harriet M Kluger; Joshua Sznol; Saadia A Aziz; Dylan Duchen; Robert L Camp
CD70 expression patterns in renal cell carcinoma.
Human pathology 2012;43(9):1394-9.
2011: Anees B Chagpar; Robert L Camp; David L Rimm
Lymph node ratio should be considered for incorporation into staging for breast cancer.
Annals of surgical oncology 2011;18(11):3143-8.
2011: Yalai Bai; Robert L Camp; Huan Cheng; Arun Gopinath; Eirini Pectasides; David L Rimm; Summar Siddiqui; Juliana Tolles; Annette M Molinaro
Quantitative assessment shows loss of antigenic epitopes as a function of pre-analytic variables.
Laboratory investigation; a journal of technical methods and pathology 2011;91(8):1253-61.
2011: Lucia B Jilaveanu; Christopher R Zito; Saadia A Aziz; Ashok Chakraborty; Michael A Davies; Robert L Camp; David L Rimm; Arkadiusz Dudek; Mario Sznol; Harriet M Kluger
In vitro studies of dasatinib, its targets and predictors of sensitivity.
Pigment cell & melanoma research 2011;24(2):386-9.
2011: Maria T Baquero; Kimberly A Bassi; Robert L Camp; Mark D Gustavson; Lyndsay N Harris; Karen Lostritto; Annette M Molinaro; Franck Appia; David L Rimm
Evaluation of prognostic and predictive value of microtubule associated protein tau in two independent cohorts.
Breast cancer research : BCR 2011;13(5):R85.
2010: Saadia A Aziz; Lucia B Jilaveanu; Christopher Zito; Robert L Camp; David L Rimm; Patricia Conrad; Harriet M Kluger
Vertical targeting of the phosphatidylinositol-3 kinase pathway as a strategy for treating melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(24):6029-39.
2010: Mark Kidd; Z-L Siddique; I Drozdov; B I Gustafsson; Robert L Camp; J W Black; M Boyce; Irvin M Modlin
The CCK(2) receptor antagonist, YF476, inhibits Mastomys ECL cell hyperplasia and gastric carcinoid tumor development.
Regulatory peptides 2010;162(1-3):52-60.
2010: Veronique Neumeister; Seema Agarwal; Jennifer Bordeaux; Robert L Camp; David L Rimm
In situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosis.
The American journal of pathology 2010;176(5):2131-8.
2010: Janice M Mehnert; Mary M McCarthy; Lucia Jilaveanu; Keith T Flaherty; Saadia Aziz; Robert L Camp; David L Rimm; Harriet M Kluger
Quantitative expression of VEGF, VEGF-R1, VEGF-R2, and VEGF-R3 in melanoma tissue microarrays.
Human pathology 2010;41(3):375-84.
2010: Y Nadler; A M González; Robert L Camp; David L Rimm; Harriet M Kluger; Yuval Kluger
Growth factor receptor-bound protein-7 (Grb7) as a prognostic marker and therapeutic target in breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(3):466-73.
2010: Marisa Dolled-Filhart; Mark Gustavson; Robert L Camp; David L Rimm; John L Tonkinson; Jason Christiansen
Automated analysis of tissue microarrays.
Methods in molecular biology (Clifton, N.J.) 2010;664():151-62.
2009: Bonnie E Gould Rothberg; Aaron J Berger; Annette M Molinaro; Antonio Subtil; Michael O Krauthammer; Robert L Camp; William R Bradley; Stephan Ariyan; Harriet M Kluger; David L Rimm
Melanoma prognostic model using tissue microarrays and genetic algorithms.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(34):5772-80.
2009: Lucia B Jilaveanu; Christopher R Zito; Saadia A Aziz; Patricia J Conrad; John C Schmitz; Mario Sznol; Robert L Camp; David L Rimm; Harriet M Kluger
C-Raf is associated with disease progression and cell proliferation in a subset of melanomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(18):5704-13.
2009: Paul Weinberger; Ziwei Yu; Panteleimon Kountourakis; Clarence Sasaki; Bruce G Haffty; Diane Kowalski; Mark A Merkley; David L Rimm; Robert L Camp; Amanda Psyrri
Defining molecular phenotypes of human papillomavirus-associated oropharyngeal squamous cell carcinoma: validation of three-class hypothesis.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2009;141(3):382-9.
2009: Jennifer Giltnane; Christopher B Moeder; Robert L Camp; David L Rimm
Quantitative multiplexed analysis of ErbB family coexpression for primary breast cancer prognosis in a large retrospective cohort.
Cancer 2009;115(11):2400-9.
2009: Saadia A Aziz; Michael Davies; Elah Pick; Christopher Zito; Lucia Jilaveanu; Robert L Camp; David L Rimm; Yuval Kluger; Harriet M Kluger
Phosphatidylinositol-3-kinase as a therapeutic target in melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(9):3029-36.
2009: Malini Harigopal; Jonas Heymann; Sriparna Ghosh; Valsamo Anagnostou; Robert L Camp; David L Rimm
Estrogen receptor co-activator (AIB1) protein expression by automated quantitative analysis (AQUA) in a breast cancer tissue microarray and association with patient outcome.
Breast cancer research and treatment 2009;115(1):77-85.
2009: Ignat Drozdov; Mark Kidd; Boaz Nadler; Robert L Camp; Shrikant M Mane; Oyvind Hauso; Bjorn I Gustafsson; Irvin M Modlin
Predicting neuroendocrine tumor (carcinoid) neoplasia using gene expression profiling and supervised machine learning.
Cancer 2009;115(8):1638-50.
2009: Panteleimon Kountourakis; Amanda Psyrri; Andreas Scorilas; Sonia Markakis; Diane Kowalski; Robert L Camp; Eleftherios P Diamandis; Meletios A Dimopoulos
Expression and prognostic significance of kallikrein-related peptidase 8 protein levels in advanced ovarian cancer by using automated quantitative analysis.
Thrombosis and haemostasis 2009;101(3):541-6.
2009: Lucia Jilaveanu; Christopher Zito; Sandra J Lee; Katherine L Nathanson; Robert L Camp; David L Rimm; Keith T Flaherty; Harriet M Kluger
Expression of sorafenib targets in melanoma patients treated with carboplatin, paclitaxel and sorafenib.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(3):1076-85.
2009: C A W Sullivan; Sankar Ghosh; Idris Tolgay Ocal; Robert L Camp; David L Rimm; Gina G Chung
Microvessel area using automated image analysis is reproducible and is associated with prognosis in breast cancer.
Human pathology 2009;40(2):156-65.
2008: Robert L Camp; Veronique Neumeister; David L Rimm
A decade of tissue microarrays: progress in the discovery and validation of cancer biomarkers.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(34):5630-7.
2008: Sriparna Ghosh; Catherine A W Sullivan; Maciej P Zerkowski; Annette M Molinaro; David L Rimm; Robert L Camp; Gina G Chung
High levels of vascular endothelial growth factor and its receptors (VEGFR-1, VEGFR-2, neuropilin-1) are associated with worse outcome in breast cancer.
Human pathology 2008;39(12):1835-43.
2008: Mark D Gustavson; Annette M Molinaro; Greg Tedeschi; Robert L Camp; David L Rimm
AQUA analysis of thymidylate synthase reveals localization to be a key prognostic biomarker in 2 large cohorts of colorectal carcinoma.
Archives of pathology & laboratory medicine 2008;132(11):1746-52.
2008: Panteleimon Kountourakis; Amanda Psyrri; Andreas Scorilas; Robert L Camp; Sonia Markakis; Diane Kowalski; Eleftherios P Diamandis; Meletios A Dimopoulos
Prognostic value of kallikrein-related peptidase 6 protein expression levels in advanced ovarian cancer evaluated by automated quantitative analysis (AQUA).
Cancer science 2008;99(11):2224-9.
2008: Harriet M Kluger; Summar F Siddiqui; Cesar Angeletti; Mario Sznol; William K Kelly; Annette M Molinaro; Robert L Camp
Classification of renal cell carcinoma based on expression of VEGF and VEGF receptors in both tumor cells and endothelial cells.
Laboratory investigation; a journal of technical methods and pathology 2008;88(9):962-72.
2008: Yasmine Nadler; Robert L Camp; Candice Schwartz; David L Rimm; Harriet M Kluger; Yuval Kluger
Expression of Aurora A (but not Aurora B) is predictive of survival in breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(14):4455-62.
2008: Amanda Psyrri; P Kountourakis; Andreas Scorilas; Sonia Markakis; Robert L Camp; Diane Kowalski; Eleftherios P Diamandis; Meletios A Dimopoulos
Human tissue kallikrein 7, a novel biomarker for advanced ovarian carcinoma using a novel in situ quantitative method of protein expression.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(7):1271-7.
2008: Mary M McCarthy; Elah Pick; Yuval Kluger; B Gould-Rothberg; Rossitza Lazova; Robert L Camp; David L Rimm; Harriet M Kluger
HSP90 as a marker of progression in melanoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(3):590-4.
2008: Yasmine Nadler; Robert L Camp; Jennifer Giltnane; Christopher Moeder; David L Rimm; Harriet M Kluger; Yuval Kluger
Expression patterns and prognostic value of Bag-1 and Bcl-2 in breast cancer.
Breast cancer research : BCR 2008;10(2):R35.
2007: Christopher Moeder; Jennifer Giltnane; Malini Harigopal; Annette M Molinaro; Andrew Robinson; Karen Gelmon; David Huntsman; Robert L Camp; David L Rimm
Quantitative justification of the change from 10% to 30% for human epidermal growth factor receptor 2 scoring in the American Society of Clinical Oncology/College of American Pathologists guidelines: tumor heterogeneity in breast cancer and its implications for tissue microarray based assessment of outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(34):5418-25.
2007: Mark Kidd; Irvin M Modlin; Michael D Shapiro; Robert L Camp; Shrikant M Mane; W Usinger; John R Murren
CTGF, intestinal stellate cells and carcinoid fibrogenesis.
World journal of gastroenterology : WJG 2007;13(39):5208-16.
2007: Gina G Chung; Maciej P Zerkowski; Sriparna Ghosh; Robert L Camp; David L Rimm
Quantitative analysis of estrogen receptor heterogeneity in breast cancer.
Laboratory investigation; a journal of technical methods and pathology 2007;87(7):662-9.
2007: Mark Kidd; Irvin M Modlin; Roswitha Pfragner; Geeta Eick; Manish C Champaneria; Anthony K C Chan; Robert L Camp; Shrikant M Mane
Small bowel carcinoid (enterochromaffin cell) neoplasia exhibits transforming growth factor-beta1-mediated regulatory abnormalities including up-regulation of C-Myc and MTA1.
Cancer 2007;109(12):2420-31.
2007: David L Rimm; Jennifer Giltnane; Christopher Moeder; Malini Harigopal; Gina G Chung; Robert L Camp; Barbara Burtness
Bimodal population or pathologist artifact?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(17):2487-8.
2007: Elah Pick; Yuval Kluger; Jennifer Giltnane; Christopher Moeder; Robert L Camp; David L Rimm; Harriet M Kluger
High HSP90 expression is associated with decreased survival in breast cancer.
Cancer research 2007;67(7):2932-7.
2007: Amanda Psyrri; Panteleimon Kountourakis; Ziwei Yu; C Papadimitriou; Sonia Markakis; Robert L Camp; Theofanis Economopoulos; Meletios A Dimopoulos
Analysis of p53 protein expression levels on ovarian cancer tissue microarray using automated quantitative analysis elucidates prognostic patient subsets.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(4):709-15.
2007: Ziwei Yu; Paul Weinberger; Clarence Sasaki; Brian L Egleston; William F Speier; Bruce G Haffty; Diane Kowalski; Robert L Camp; David L Rimm; Eleftherios Vairaktaris; Barbara Burtness; Amanda Psyrri
Phosphorylation of Akt (Ser473) predicts poor clinical outcome in oropharyngeal squamous cell cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(3):553-8.
2007: Sharon Pozner-Moulis; Melissa Cregger; Robert L Camp; David L Rimm
Antibody validation by quantitative analysis of protein expression using expression of Met in breast cancer as a model.
Laboratory investigation; a journal of technical methods and pathology 2007;87(3):251-60.
2007: Maciej P Zerkowski; Robert L Camp; Barbara Burtness; David L Rimm; Gina G Chung
Quantitative analysis of breast cancer tissue microarrays shows high cox-2 expression is associated with poor outcome.
Cancer investigation 2007;25(1):19-26.
2007: Harriet M Kluger; Mary M McCarthy; Ayesha B Alvero; Mario Sznol; Stephan Ariyan; Robert L Camp; David L Rimm; Gil Mor
The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by Phenoxodiol is associated with Carboplatin sensitization.
Journal of translational medicine 2007;5():6.
2007: Mark Kidd; Irvin M Modlin; Geeta Eick; Robert L Camp; Shrikant M Mane
Role of CCN2/CTGF in the proliferation of Mastomys enterochromaffin-like cells and gastric carcinoid development.
American journal of physiology. Gastrointestinal and liver physiology 2007;292(1):G191-200.
2006: Aristotelis Bamias; Ziwei Yu; Paul Weinberger; Sonia Markakis; Diane Kowalski; Robert L Camp; David L Rimm; Meletios A Dimopoulos; Amanda Psyrri
Automated quantitative analysis of DCC tumor suppressor protein in ovarian cancer tissue microarray shows association with beta-catenin levels and outcome in patients with epithelial ovarian cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(12):1797-802.
2006: Marisa Dolled-Filhart; Lisa Rydén; Melissa Cregger; Karin Jirström; Malini Harigopal; Robert L Camp; David L Rimm
Classification of breast cancer using genetic algorithms and tissue microarrays.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(21):6459-68.
2006: Irvin M Modlin; Mark Kidd; Igor Latich; Michelle Nabulumba Zikusoka; Geeta Eick; Shrikant M Mane; Robert L Camp
Genetic differentiation of appendiceal tumor malignancy: a guide for the perplexed.
Annals of surgery 2006;244(1):52-60.
2006: Mary M McCarthy; Kyle A DiVito; Mario Sznol; Daniela Kovacs; Ruth Halaban; Aaron J Berger; Keith T Flaherty; Robert L Camp; Rossitza Lazova; David L Rimm; Harriet M Kluger
Expression of tumor necrosis factor--related apoptosis-inducing ligand receptors 1 and 2 in melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(12):3856-63.
2006: Amanda Psyrri; Ziwei Yu; Aristotelis Bamias; Paul Weinberger; Sonia Markakis; Diane Kowalski; Robert L Camp; David L Rimm; Meletios A Dimopoulos
Evaluation of the prognostic value of cellular inhibitor of apoptosis protein in epithelial ovarian cancer using automated quantitative protein analysis.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(6):1179-83.
2006: Marisa Dolled-Filhart; Anthony McCabe; Jennifer Giltnane; Melissa Cregger; Robert L Camp; David L Rimm
Quantitative in situ analysis of beta-catenin expression in breast cancer shows decreased expression is associated with poor outcome.
Cancer research 2006;66(10):5487-94.
2006: Gina G Chung; Harry H Yoon; Maciej P Zerkowski; Sriparna Ghosh; Laurie Thomas; Malini Harigopal; Lori A Charette; Ronald R Salem; Robert L Camp; David L Rimm; Barbara Burtness
Vascular endothelial growth factor, FLT-1, and FLK-1 analysis in a pancreatic cancer tissue microarray.
Cancer 2006;106(8):1677-84.
2006: Mark Kidd; Irvin M Modlin; Shrikant M Mane; Robert L Camp; Geeta Eick; Igor Latich; Michelle Nabulumba Zikusoka
Utility of molecular genetic signatures in the delineation of gastric neoplasia.
Cancer 2006;106(7):1480-8.
2006: Paul Weinberger; Ziwei Yu; Bruce G Haffty; Diane Kowalski; Malini Harigopal; Janet L Brandsma; Clarence Sasaki; John K Joe; Robert L Camp; David L Rimm; Amanda Psyrri
Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(5):736-47.
2006: Mark Kidd; Irvin M Modlin; Shrikant M Mane; Robert L Camp; Michael D Shapiro
Q RT-PCR detection of chromogranin A: a new standard in the identification of neuroendocrine tumor disease.
Annals of surgery 2006;243(2):273-80.
2006: Mark Kidd; Irvin M Modlin; Shrikant M Mane; Robert L Camp; Geeta Eick; Igor Latich
The role of genetic markers--NAP1L1, MAGE-D2, and MTA1--in defining small-intestinal carcinoid neoplasia.
Annals of surgical oncology 2006;13(2):253-62.
2005: Anthony McCabe; Marisa Dolled-Filhart; Robert L Camp; David L Rimm
Automated quantitative analysis (AQUA) of in situ protein expression, antibody concentration, and prognosis.
Journal of the National Cancer Institute 2005;97(24):1808-15.
2005: Amanda Psyrri; Mohamad Kassar; Ziwei Yu; Aristotelis Bamias; Paul Weinberger; Sonia Markakis; Diane Kowalski; Robert L Camp; David L Rimm; Meletios A Dimopoulos
Effect of epidermal growth factor receptor expression level on survival in patients with epithelial ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(24 Pt 1):8637-43.
2005: Amanda Psyrri; Aristotelis Bamias; Ziwei Yu; Paul Weinberger; Mohamad Kassar; Sonia Markakis; Diane Kowalski; Eleni Efstathiou; Robert L Camp; David L Rimm; Meletios A Dimopoulos
Subcellular localization and protein levels of cyclin-dependent kinase inhibitor p27 independently predict for survival in epithelial ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(23):8384-90.
2005: Summar F Siddiqui; John Pawelek; Tamara Handerson; Chen-Yong Lin; Robert B Dickson; David L Rimm; Robert L Camp
Coexpression of beta1,6-N-acetylglucosaminyltransferase V glycoprotein substrates defines aggressive breast cancers with poor outcome.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(11 Pt 1):2517-23.
2005: Amanda Psyrri; Ziwei Yu; Paul Weinberger; Clarence Sasaki; Bruce G Haffty; Robert L Camp; David L Rimm; Barbara Burtness
Quantitative determination of nuclear and cytoplasmic epidermal growth factor receptor expression in oropharyngeal squamous cell cancer by using automated quantitative analysis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(16):5856-62.
2005: Mary M McCarthy; Mario Sznol; Kyle A DiVito; Robert L Camp; David L Rimm; Harriet M Kluger
Evaluating the expression and prognostic value of TRAIL-R1 and TRAIL-R2 in breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(14):5188-94.
2005: Harriet M Kluger; Dina Chelouche Lev; Yuval Kluger; Mary M McCarthy; Galina Kiriakova; Robert L Camp; David L Rimm; Janet E Price
Using a xenograft model of human breast cancer metastasis to find genes associated with clinically aggressive disease.
Cancer research 2005;65(13):5578-87.
2005: Malini Harigopal; Aaron J Berger; Robert L Camp; David L Rimm; Harriet M Kluger
Automated quantitative analysis of E-cadherin expression in lymph node metastases is predictive of survival in invasive ductal breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(11):4083-9.
2005: Tamara Handerson; Robert L Camp; Malini Harigopal; David L Rimm; John Pawelek
Beta1,6-branched oligosaccharides are increased in lymph node metastases and predict poor outcome in breast carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(8):2969-73.
2005: Ziwei Yu; Paul Weinberger; Elayne Provost; Bruce G Haffty; Clarence Sasaki; John K Joe; Robert L Camp; David L Rimm; Amanda Psyrri
beta-Catenin functions mainly as an adhesion molecule in patients with squamous cell cancer of the head and neck.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(7):2471-7.
2005: Ziwei Yu; Paul Weinberger; Bruce G Haffty; Clarence Sasaki; Cynthia Zerillo; John K Joe; Diane Kowalski; James Dziura; Robert L Camp; David L Rimm; Amanda Psyrri
Cyclin d1 is a valuable prognostic marker in oropharyngeal squamous cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(3):1160-6.
2005: Mark Kidd; Geeta Eick; Michael D Shapiro; Robert L Camp; Shrikant M Mane; Irvin M Modlin
Microsatellite instability and gene mutations in transforming growth factor-beta type II receptor are absent in small bowel carcinoid tumors.
Cancer 2005;103(2):229-36.
2004: Kyle A DiVito; Aaron J Berger; Robert L Camp; Marisa Dolled-Filhart; David L Rimm; Harriet M Kluger
Automated quantitative analysis of tissue microarrays reveals an association between high Bcl-2 expression and improved outcome in melanoma.
Cancer research 2004;64(23):8773-7.
2004: Aaron J Berger; Robert L Camp; Kyle A DiVito; Harriet M Kluger; Ruth Halaban; David L Rimm
Automated quantitative analysis of HDM2 expression in malignant melanoma shows association with early-stage disease and improved outcome.
Cancer research 2004;64(23):8767-72.
2004: Robert L Camp; Marisa Dolled-Filhart; David L Rimm
X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(21):7252-9.
2004: Kyle A DiVito; Lori A Charette; David L Rimm; Robert L Camp
Long-term preservation of antigenicity on tissue microarrays.
Laboratory investigation; a journal of technical methods and pathology 2004;84(8):1071-8.
2004: Harriet M Kluger; Kyle A DiVito; Aaron J Berger; Ruth Halaban; Stephan Ariyan; Robert L Camp; David L Rimm
Her2/neu is not a commonly expressed therapeutic target in melanoma -- a large cohort tissue microarray study.
Melanoma research 2004;14(3):207-10.
2004: Gina G Chung; Maciej P Zerkowski; Idris Tolgay Ocal; Marisa Dolled-Filhart; Jung Y Kang; Amanda Psyrri; Robert L Camp; David L Rimm
beta-Catenin and p53 analyses of a breast carcinoma tissue microarray.
Cancer 2004;100(10):2084-92.
2004: Mark A Rubin; Maciej P Zerkowski; Robert L Camp; Rainer Kuefer; Matthias D Hofer; Arul M Chinnaiyan; David L Rimm
Quantitative determination of expression of the prostate cancer protein alpha-methylacyl-CoA racemase using automated quantitative analysis (AQUA): a novel paradigm for automated and continuous biomarker measurements.
The American journal of pathology 2004;164(3):831-40.
2004: Harriet M Kluger; Marisa Dolled-Filhart; Sofya Rodov; Barry M Kacinski; Robert L Camp; David L Rimm
Macrophage colony-stimulating factor-1 receptor expression is associated with poor outcome in breast cancer by large cohort tissue microarray analysis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(1 Pt 1):173-7.
2003: Ginesa Garcia-Rostan; Hongyu Zhao; Robert L Camp; Marina Pollan; Agustin Herrero; Javier Pardo; Ran Wu; Maria Luisa Carcangiu; Jose Costa; Giovanni Tallini
ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(17):3226-35.
2003: Idris Tolgay Ocal; Marisa Dolled-Filhart; Thomas G D'Aquila; Robert L Camp; David L Rimm
Tissue microarray-based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not correlated with epidermal growth factor family receptors.
Cancer 2003;97(8):1841-8.
2003: Robert L Camp; Marisa Dolled-Filhart; Bonnie L King; David L Rimm
Quantitative analysis of breast cancer tissue microarrays shows that both high and normal levels of HER2 expression are associated with poor outcome.
Cancer research 2003;63(7):1445-8.
2003: Jung Y Kang; Marisa Dolled-Filhart; Idris Tolgay Ocal; Baljit Singh; Chen-Yong Lin; Robert B Dickson; David L Rimm; Robert L Camp
Tissue microarray analysis of hepatocyte growth factor/Met pathway components reveals a role for Met, matriptase, and hepatocyte growth factor activator inhibitor 1 in the progression of node-negative breast cancer.
Cancer research 2003;63(5):1101-5.
2003: Eric Kielhorn; Elayne Provost; Drew Olsen; Thomas G D'Aquila; Bradley L Smith; Robert L Camp; David L Rimm
Tissue microarray-based analysis shows phospho-beta-catenin expression in malignant melanoma is associated with poor outcome.
International journal of cancer. Journal international du cancer 2003;103(5):652-6.
2003: Marisa Dolled-Filhart; Robert L Camp; Diane Kowalski; Bradley L Smith; David L Rimm
Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear localization is associated with a better prognosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(2):594-600.
2002: Robert L Camp; Gina G Chung; David L Rimm
Automated subcellular localization and quantification of protein expression in tissue microarrays.
Nature medicine 2002;8(11):1323-7.
2002: Massimo Santoro; Mauro Papotti; Gennaro Chiappetta; Ginesa Garcia-Rostan; Marco Volante; Chaline Johnson; Robert L Camp; Francesca Pentimalli; Carmen Monaco; Agustin Herrero; Maria Luisa Carcangiu; Alfredo Fusco; Giovanni Tallini
RET activation and clinicopathologic features in poorly differentiated thyroid tumors.
The Journal of clinical endocrinology and metabolism 2002;87(1):370-9.
2001: David L Rimm; Robert L Camp; Lori A Charette; D A Olsen; Elayne Provost
Amplification of tissue by construction of tissue microarrays.
Experimental and molecular pathology 2001;70(3):255-64.
2001: Ginesa Garcia-Rostan; Robert L Camp; Agustin Herrero; Maria Luisa Carcangiu; David L Rimm; Giovanni Tallini
Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis.
The American journal of pathology 2001;158(3):987-96.
2001: David L Rimm; Robert L Camp; Lori A Charette; J Costa; D A Olsen; M Reiss
Tissue microarray: a new technology for amplification of tissue resources.
Cancer journal (Sudbury, Mass.) 2001;7(1):24-31.
2000: Robert L Camp; Lori A Charette; David L Rimm
Validation of tissue microarray technology in breast carcinoma.
Laboratory investigation; a journal of technical methods and pathology 2000;80(12):1943-9.
2000: Robert L Camp; EB Rimm; David L Rimm
A high number of tumor free axillary lymph nodes from patients with lymph node negative breast carcinoma is associated with poor outcome.
Cancer 2000;88(1):108-13.
1999: Robert L Camp; EB Rimm; David L Rimm
Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma.
Cancer 1999;86(11):2259-65.